OSG OCTAVE SPECIALTY GROUP INC
Surety Insurance · NYSE · SEC CIK 874501 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q22025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $85.34M | $83.00M | $104.17M | $66.90M | $66.61M | $54.96M | $62.76M | $65.22M |
| SG&A expense | $52.00M | $51.41M | $53.16M | $58.84M | $53.71M | $40.54M | $38.53M | $40.44M |
| Interest expense | $2.71M | $2.77M | $2.09M | $1.43M | $6.18M | $5.57M | $5.45M | -$41.62M |
| Pretax income | -$13.38M | -$11.67M | -$3.34M | -$30.85M | -$32.08M | -$22.97M | -$15.11M | -$21.10M |
| Income tax | -$521,000 | $485,000 | -$481,000 | $9.24M | -$1.24M | -$2.17M | -$617,000 | $1.69M |
| Net income | -$13.80M | -$12.16M | -$6.85M | -$27.38M | -$112.62M | -$72.95M | -$46.39M | -$548.26M |
| EPS (basic) | -0.31 | -0.33 | -0.13 | — | -2.33 | -1.51 | -1.21 | -10.23 |
| EPS (diluted) | -0.31 | -0.33 | -0.13 | — | -2.33 | -1.51 | -1.21 | -10.23 |
| Weighted avg. shares (diluted) | 45.42M | 45.39M | 45.30M | — | 48.11M | 48.12M | 47.31M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $79.15M | $79.10M | $93.54M | $68.44M | $51.77M | $46.38M | $51.66M | $47.27M |
| Short-term investments | $93.41M | $82.51M | $229.39M | $146.44M | $426.93M | $264.06M | $263.18M | $127.60M |
| Receivables | $94.61M | $100.54M | $106.20M | $86.55M | $75.48M | $72.62M | $65.82M | $55.38M |
| Goodwill | $534.16M | $534.30M | $533.50M | $540.35M | $445.38M | $451.81M | $429.31M | $418.23M |
| Intangibles | $435.83M | $447.45M | $458.38M | $475.00M | $339.20M | $353.90M | $345.06M | $344.77M |
| Total assets | $2.30B | $2.28B | $2.27B | $2.22B | $2.15B | $8.52B | $8.25B | $8.06B |
| Short-term debt | — | — | $0 | $0 | $0 | $150.00M | $150.00M | $150.00M |
| Long-term debt | $154.77M | $155.46M | $117.06M | $117.56M | — | — | — | $0 |
| Total debt | $154.77M | $155.46M | $117.06M | $117.56M | — | — | — | $150.00M |
| Total liabilities | $1.30B | $1.27B | $1.24B | $1.14B | $1.00B | $7.30B | $7.04B | $6.86B |
| Shareholders' equity | $684.39M | $698.75M | $712.62M | $715.79M | $843.38M | $859.84M | $852.22M | $798.36M |
| Net debt | $75.62M | $76.36M | $23.52M | $49.12M | — | — | — | $102.72M |
| Shares outstanding | 45.05M | 45.02M | 45.01M | 45.01M | 46.70M | 46.40M | 46.43M | 46.51M |
| Cash flow statement | ||||||||
| Operating cash flow | $19.30M | -$10.23M | -$10.08M | -$666,000 | -$41.15M | $2.15M | -$12.61M | -$27.24M |
| Investing cash flow | -$14.94M | $10.31M | $37.71M | -$65.44M | $247.34M | -$3.31M | $21.34M | $33.63M |
| Financing cash flow | -$4.44M | -$14.26M | -$2.13M | $232.08M | -$200.98M | -$4.31M | -$5.44M | -$178.22M |
| Depreciation & amortization | $12.31M | $12.26M | $12.21M | $13.29M | $9.75M | $9.74M | $9.18M | $9.62M |
| Stock-based compensation | $4.33M | $4.15M | $4.72M | $2.78M | $2.14M | $2.44M | $2.35M | $3.36M |
| Share buybacks | $0 | — | — | $26.64M | $6.60M | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 51 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.